{"id":83590,"date":"2026-04-01T16:19:05","date_gmt":"2026-04-01T16:19:05","guid":{"rendered":"https:\/\/teeptrak.com\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/"},"modified":"2026-04-01T16:19:09","modified_gmt":"2026-04-01T16:19:09","slug":"pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026","status":"publish","type":"post","link":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/","title":{"rendered":"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27&#8243;][et_pb_row][et_pb_column type=&#8221;4_4&#8243;][et_pb_text _builder_version=&#8221;4.27&#8243;]<\/p>\n<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"BlogPosting\",\n  \"headline\": \"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026\",\n  \"description\": \"How to measure and improve OEE in pharmaceutical manufacturing before INTERPHEX 2026. Real data from 450+ plants: average pharma OEE is 63%. Here is how to close the gap.\",\n  \"image\": \"https:\/\/teeptrak.com\/wp-content\/uploads\/pharmaceutical-oee-monitoring.jpg\",\n  \"author\": {\n    \"@type\": \"Organization\",\n    \"name\": \"TeepTrak\"\n  },\n  \"publisher\": {\n    \"@type\": \"Organization\",\n    \"name\": \"TeepTrak\",\n    \"logo\": {\n      \"@type\": \"ImageObject\",\n      \"url\": \"https:\/\/teeptrak.com\/wp-content\/uploads\/teeptrak-logo.png\"\n    }\n  },\n  \"datePublished\": \"2024-12-19\",\n  \"dateModified\": \"2024-12-19\",\n  \"mainEntityOfPage\": {\n    \"@type\": \"WebPage\",\n    \"@id\": \"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/\"\n  }\n}\n<\/script><\/p>\n<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is the average OEE in pharmaceutical manufacturing?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"The average OEE in pharmaceutical manufacturing ranges from 55-65%, significantly below the world-class benchmark of 85%. TeepTrak pharma clients achieve an average improvement of +11 OEE points within 5 months of implementation.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How does pharma OEE differ from automotive OEE?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Pharma OEE differs through batch production complexity, extensive changeover procedures requiring CIP\/SIP cleaning cycles lasting 4-8 hours, stringent regulatory documentation requirements, and equipment qualification downtimes for IQ\/OQ\/PQ protocols that can extend for days.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is TeepTrak compliant with FDA 21 CFR Part 11 requirements?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Yes, TeepTrak maintains full FDA 21 CFR Part 11 compliance with electronic records and signatures, audit trails, data integrity following ALCOA+ principles, and secure user access controls required for regulated pharmaceutical environments.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What are the biggest OEE killers in pharmaceutical plants?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"The six biggest OEE killers are: CIP\/SIP cleaning cycles (4-8 hours per changeover), equipment qualification downtime, batch record completion delays, in-process control failures, product changeovers, and micro-stoppages on filling and pressing lines that remain invisible without IoT monitoring.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How long does TeepTrak installation take in pharmaceutical facilities?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"TeepTrak installation requires approximately 30 minutes per machine with zero production interruption. The wireless IoT sensors are designed for FDA\/GMP environments and can provide live OEE data within 48 hours of installation.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What ROI can pharmaceutical companies expect from OEE improvements?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"For a typical $500M revenue pharmaceutical plant, each OEE percentage point represents $2-5M in annual value. TeepTrak clients typically achieve payback within 6-12 months through improved production capacity and reduced compliance risks.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How should pharmaceutical companies prepare for INTERPHEX 2026?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Companies should establish baseline OEE measurements before attending INTERPHEX 2026, prepare specific questions about FDA 21 CFR Part 11 compliance, deployment timelines, and batch management system integration to effectively evaluate IoT monitoring solutions.\"\n      }\n    }\n  ]\n}\n<\/script><\/p>\n<h1>Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026<\/h1>\n<p>The pharmaceutical industry presents a striking paradox that challenges operational excellence professionals worldwide. Despite being one of the most regulated and highest-margin industries globally, with profit margins often exceeding 20-30%, the average OEE in pharmaceutical manufacturing hovers between just 55-65%. This performance gap becomes even more pronounced when compared to world-class manufacturing benchmarks of 85% or higher achieved in automotive and electronics sectors.<\/p>\n<p>With INTERPHEX 2026 approaching\u2014the premier pharmaceutical manufacturing and packaging event\u2014plant managers and operations directors have a strategic opportunity to benchmark their current performance against industry leaders and identify the monitoring technologies that can close this substantial efficiency gap. The convergence of IoT sensing capabilities, FDA-compliant data architectures, and real-time analytics now makes it possible for pharmaceutical manufacturers to achieve automotive-level OEE performance while maintaining full regulatory compliance.<\/p>\n<p>Recent data from TeepTrak deployments across 450+ manufacturing facilities reveals that pharmaceutical clients achieve an average improvement of +11 OEE points within just 5 months of implementation. For a typical pharmaceutical plant generating $500M in annual revenue, this improvement translates directly to $22-55M in additional production capacity value\u2014without requiring any additional capital equipment investment.<\/p>\n<h2>What is OEE in Pharmaceutical Manufacturing?<\/h2>\n<p>Overall Equipment Effectiveness (OEE) in pharmaceutical manufacturing applies the same fundamental formula as other industries\u2014Availability \u00d7 Performance \u00d7 Quality\u2014but the underlying loss categories reflect the unique complexities of regulated pharmaceutical production environments.<\/p>\n<p><strong>Availability losses<\/strong> in pharmaceutical manufacturing extend far beyond simple mechanical breakdowns. CIP (Clean-in-Place) and SIP (Sterilize-in-Place) procedures between product changeovers consume 4-8 hours per cycle, often extended unnecessarily due to inadequate monitoring of cleaning validation parameters. Equipment qualification activities including Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) can remove production lines from service for days or weeks. Batch record documentation delays frequently create artificial downtime while operators complete paper-based recording requirements.<\/p>\n<p><strong>Performance losses<\/strong> manifest differently in pharmaceutical batch production compared to continuous manufacturing industries. Micro-stoppages on capsule filling lines, tablet pressing equipment, and lyophilization systems often remain invisible to operators but can reduce line speeds by 15-25% over an entire shift. Product changeovers requiring complete equipment teardown, cleaning validation, and setup verification consume significantly more time than automotive industry changeovers.<\/p>\n<p><strong>Quality losses<\/strong> in pharmaceutical manufacturing carry exponentially higher costs due to regulatory implications. In-process control failures triggering line stops, batch rejections due to out-of-specification results, and rework procedures all directly impact OEE while generating substantial regulatory documentation burdens.<\/p>\n<p>Industry benchmark analysis reveals that average pharmaceutical OEE performance of 55-65% significantly underperforms world-class manufacturing standards. TeepTrak client data from pharmaceutical installations demonstrates that facilities achieving 75-80% OEE through IoT monitoring represent the current industry leaders, while world-class performance above 85% remains achievable for pharmaceutical operations implementing comprehensive real-time monitoring strategies.<\/p>\n<p>The fundamental difference between pharmaceutical OEE and automotive OEE lies in batch production complexity, regulatory documentation requirements, and the extended duration of changeover procedures. While automotive manufacturers can complete product changeovers in minutes, pharmaceutical changeovers requiring complete CIP\/SIP cycles, equipment requalification, and batch record initiation consume hours or days.<\/p>\n<h2>FDA Compliance and OEE Data<\/h2>\n<p>The FDA has increasingly emphasized the importance of real-time production data collection and analysis as fundamental components of modern pharmaceutical manufacturing quality systems. The 21 CFR Part 11 regulations governing electronic records and signatures establish the framework within which OEE data collection must operate in FDA-regulated facilities.<\/p>\n<p>The FDA Modernization Act and subsequent guidance documents have promoted Process Analytical Technology (PAT) initiatives that encourage real-time monitoring and control of manufacturing processes. OEE data collection aligns directly with PAT principles by providing continuous visibility into equipment performance, process capability, and quality trends that support science-based manufacturing decisions.<\/p>\n<p>Pharmaceutical manufacturers must integrate OEE data into batch production records and Annual Product Reviews (APRs) as evidence of process control and continuous improvement activities. The FDA expects manufacturers to demonstrate that they understand their processes through data collection and analysis, making OEE monitoring a regulatory expectation rather than simply an operational optimization tool.<\/p>\n<p>Data integrity requirements following ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available) apply directly to OEE data collection systems. Traditional paper-based OEE recording methods fail multiple ALCOA+ criteria, particularly contemporaneous recording and data completeness requirements.<\/p>\n<p>TeepTrak maintains full FDA 21 CFR Part 11 compliance through electronic signature capabilities, comprehensive audit trails, user access controls, and data encryption protocols specifically designed for regulated pharmaceutical environments. The system automatically timestamps all data collection events, maintains complete revision histories, and provides the documentation required for FDA inspections.<\/p>\n<p>During FDA inspections, investigators increasingly request production efficiency data as evidence of process understanding and control strategy effectiveness. Facilities without comprehensive OEE monitoring systems struggle to provide the quantitative evidence that demonstrates operational excellence and regulatory compliance.<\/p>\n<h2>The 6 Biggest OEE Killers in Pharma Plants<\/h2>\n<p><strong>1. CIP\/SIP Cleaning Cycles Between Batches<\/strong><\/p>\n<p>Clean-in-Place and Sterilize-in-Place procedures represent the single largest availability loss in pharmaceutical manufacturing, consuming 4-8 hours per product changeover. Many facilities extend these cycles unnecessarily due to inadequate real-time monitoring of cleaning validation parameters such as conductivity, pH, and temperature profiles. TeepTrak installations have identified cleaning cycle optimization opportunities that reduce average CIP duration by 20-30% through precise monitoring of cleaning effectiveness endpoints. For a filling line processing 12 batches monthly, reducing CIP time from 6 hours to 4.5 hours per changeover creates 18 additional production hours monthly\u2014equivalent to $450,000-$900,000 in additional capacity value for high-value pharmaceutical products.<\/p>\n<p><strong>2. Equipment Qualification and Revalidation Downtime<\/strong><\/p>\n<p>IQ\/OQ\/PQ activities remove critical production equipment from service for extended periods, often 3-7 days per qualification cycle. Many pharmaceutical facilities lack visibility into equipment performance trends that could predict optimal requalification timing, leading to either premature equipment removal or delayed qualifications that create compliance risks. Real-time OEE monitoring provides the performance data necessary to optimize qualification scheduling and minimize production impact.<\/p>\n<p><strong>3. Batch Record Completion and Review Delays<\/strong><\/p>\n<p>Paper-based batch record systems create artificial downtime while operators complete documentation requirements between production activities. Manufacturing execution delays of 15-45 minutes between batch steps accumulate throughout multi-step pharmaceutical processes, reducing overall line efficiency by 8-15%. Electronic batch record integration with real-time OEE data eliminates manual transcription requirements and accelerates batch record review cycles.<\/p>\n<p><strong>4. In-Process Control Failures Triggering Line Stops<\/strong><\/p>\n<p>Pharmaceutical manufacturing requires extensive in-process testing that can halt production when results fall outside specifications. Tablet weight variation, capsule fill uniformity, and dissolution testing failures force immediate line stops that consume 30-90 minutes per incident. Facilities processing 50-100 batches monthly experience 15-25 in-process control stops, representing 8-40 hours of monthly downtime. Real-time process monitoring can predict control failures before they occur, enabling preventive adjustments that maintain production continuity.<\/p>\n<p><strong>5. Changeover from One Product to Another<\/strong><\/p>\n<p>Pharmaceutical product changeovers extend far beyond simple material substitution, requiring complete equipment teardown, cleaning validation, setup verification, and batch record initiation. Average changeover duration ranges from 6-12 hours depending on product similarity and contamination risk assessment. High-potency compound changeovers requiring complete equipment disassembly can consume 24-48 hours. Optimizing changeover sequences and procedures through data-driven analysis can reduce changeover time by 25-40%.<\/p>\n<p><strong>6. Micro-Stoppages on Capsule Filling, Tablet Pressing, Lyophilization Lines<\/strong><\/p>\n<p>Short-duration equipment stops lasting 30 seconds to 5 minutes remain invisible to operators but accumulate throughout production shifts to reduce effective line speeds by 15-25%. Capsule filling lines experience micro-stops from powder bridging, capsule jams, and dosing system adjustments. Tablet presses encounter tooling adjustments, powder flow interruptions, and weight check delays. Lyophilization equipment suffers from vial handling delays, vacuum system fluctuations, and temperature control adjustments. Without IoT sensors providing precise stop\/start timestamps, these losses remain hidden in overall production reporting while significantly impacting OEE performance.<\/p>\n<h2>How IoT Monitoring Transforms Pharma OEE<\/h2>\n<p>The transformation from paper-based to IoT-enabled OEE collection in pharmaceutical manufacturing reveals systematic measurement gaps that have masked true equipment performance for decades. Traditional paper-based OEE reporting typically overstates actual performance by 10-15 percentage points due to operator estimation errors, measurement timing gaps, and unconscious bias toward higher reported efficiency numbers.<\/p>\n<p>TeepTrak IoT sensor installation in pharmaceutical facilities requires approximately 30 minutes per machine with zero production interruption. The wireless sensor architecture specifically designed for FDA\/GMP environments eliminates the need for hardwired connections that could compromise equipment validation status. Sensors monitor machine state, production counts, quality parameters, and operator activities in real-time, providing comprehensive OEE data collection that meets 21 CFR Part 11 requirements.<\/p>\n<p>A concrete case study from a pharmaceutical filling line installation demonstrates the transformative impact of IoT monitoring. The 12-machine aseptic filling line had reported OEE performance of 74% through manual data collection methods. TeepTrak IoT sensors revealed actual OEE performance of 61%\u2014a 13-point measurement gap that represented $2.6M in misunderstood production capacity.<\/p>\n<p>Within the first week of IoT monitoring, three root causes emerged that had remained invisible under paper-based measurement:<\/p>\n<p>First, micro-stoppages during vial feeding consumed 47 minutes per shift due to intermittent jam conditions that operators cleared quickly but failed to document consistently. Second, CIP cycle extensions added 90 minutes per changeover because operators lacked real-time visibility into cleaning validation parameter achievement. Third, in-process control sampling procedures interrupted production for 12 minutes per hour due to inefficient sampling point access and documentation requirements.<\/p>\n<p>Implementation of targeted improvement actions addressing these three root causes achieved +11 OEE points within 5 months, reaching 72% OEE performance. The annual production capacity improvement translated to $2.1M in additional revenue without any capital equipment investment. Multi-site rollout across the pharmaceutical group extended these improvements to 8 additional facilities, generating $18M in aggregate annual value.<\/p>\n<p>The IoT monitoring transformation extends beyond simple measurement accuracy to enable predictive analytics, automated reporting, and real-time decision support that fundamentally changes how pharmaceutical operations teams manage equipment effectiveness. Integration with existing batch management systems provides seamless data flow that eliminates manual transcription while maintaining full audit trail compliance.<\/p>\n<h2>How to Use INTERPHEX 2026 to Benchmark Your OEE Strategy<\/h2>\n<p>Pharmaceutical manufacturing professionals attending INTERPHEX 2026 must complete essential preparatory work before evaluating IoT monitoring and MES solutions. Without establishing baseline OEE measurements, attendees cannot effectively assess the potential value proposition of different technology providers or make informed investment decisions.<\/p>\n<p>Pre-show homework requires measuring current OEE performance across critical production lines using consistent methodology and time periods. Facilities should collect at least 4 weeks of production data covering multiple product changeovers, planned maintenance activities, and typical operational variations. This baseline measurement reveals the actual performance gap that technology solutions must address and provides the foundation for calculating return on investment projections.<\/p>\n<p>When evaluating IoT and MES vendors at INTERPHEX, pharmaceutical professionals should prepare specific technical questions that differentiate between compliant solutions and systems that may create regulatory compliance risks:<\/p>\n<p>FDA 21 CFR Part 11 compliance documentation must be readily available and comprehensive, covering electronic signatures, audit trails, user access controls, and data integrity protocols. Vendors unable to provide detailed compliance documentation likely lack the pharmaceutical industry expertise necessary for successful regulated environment deployments.<\/p>\n<p>Deployment timelines on existing pharmaceutical equipment should be quantified in hours per machine rather than weeks per facility. Solutions requiring extensive equipment modification, production shutdowns, or revalidation activities may not provide acceptable implementation feasibility for pharmaceutical manufacturers operating under tight production schedules.<\/p>\n<p>Integration capabilities with existing batch management systems, laboratory information systems, and enterprise resource planning platforms determine whether new OEE monitoring systems can provide seamless data flow or will create additional data silos requiring manual intervention.<\/p>\n<p>Multi-site dashboard capabilities enable pharmaceutical groups to compare performance across facilities, identify best practices, and implement standardized improvement methodologies. Single-site solutions may not scale effectively for organizations operating multiple manufacturing locations.<\/p>\n<p>Critical red flags to avoid include vendors who cannot provide live OEE data within 48 hours of installation, systems requiring extensive custom programming for basic pharmaceutical applications, and solutions lacking pharmaceutical industry reference installations. Technology providers focused primarily on automotive or discrete manufacturing may lack the process industry expertise necessary for successful pharmaceutical implementations.<\/p>\n<p>TeepTrak offers INTERPHEX 2026 attendees the opportunity to schedule live facility demonstrations showcasing actual pharmaceutical OEE monitoring installations. <a href=\"https:\/\/teeptrak.com\/en\/solution\/\">The comprehensive solution portfolio<\/a> includes FDA-compliant data architectures, wireless IoT sensors, and multi-site analytics platforms specifically designed for pharmaceutical manufacturing environments.<\/p>\n<h2>Building the Business Case for Pharma OEE Investment<\/h2>\n<p>Developing compelling ROI calculations for pharmaceutical OEE investments requires understanding the unique value drivers that differentiate pharmaceutical manufacturing from other industries. The business case must account for production capacity value, regulatory compliance benefits, and risk mitigation factors that extend beyond simple efficiency improvements.<\/p>\n<p>The fundamental ROI calculation methodology for pharmaceutical OEE investments begins with determining the value per OEE percentage point. This calculation multiplies current production capacity by product contribution margins to establish the revenue impact of efficiency improvements. For pharmaceutical products with margins exceeding 70-80%, relatively small OEE improvements generate substantial financial returns.<\/p>\n<p>A representative example demonstrates the financial impact scale: A pharmaceutical plant generating $500M in annual revenue operating at 60% OEE has theoretical maximum capacity of $833M if achieving 100% OEE. Each OEE percentage point represents $5.55M in additional production capacity. Even achieving a modest 5-point OEE improvement creates $27.8M in additional annual capacity value.<\/p>\n<p>However, pharmaceutical ROI calculations must account for market demand constraints and regulatory approval limitations that may prevent full utilization of additional capacity. Conservative modeling should apply capacity utilization factors of 70-85% to account for demand variability and regulatory constraints. Using an 80% utilization factor, the 5-point OEE improvement generates $22.2M in realizable annual value.<\/p>\n<p>IoT OEE monitoring system investments typically range from $50,000-$200,000 per production line depending on complexity and integration requirements. Using the conservative capacity value calculation, payback periods range from 3-9 months for typical pharmaceutical manufacturing applications.<\/p>\n<p>Regulatory compliance value represents a critical but often overlooked component of pharmaceutical OEE investment justification. FDA warning letters for manufacturing quality issues typically cost pharmaceutical companies $10-50M minimum in remediation activities, production delays, and regulatory response requirements. OEE monitoring systems that provide comprehensive production data and trend analysis significantly reduce the risk of receiving FDA warning letters by demonstrating process control and continuous improvement.<\/p>\n<p>Getting CFO buy-in for pharmaceutical OEE investments requires presenting the business case in terms of risk-adjusted return calculations that account for both upside capacity value and downside regulatory risk mitigation. The combination of short payback periods, high-margin product impact, and regulatory compliance benefits creates compelling investment justification for pharmaceutical OEE monitoring systems.<\/p>\n<p>Additional value drivers include reduced validation costs through automated data collection, improved audit readiness through comprehensive documentation, and enhanced operational decision-making through real-time performance visibility. <a href=\"https:\/\/teeptrak.com\/en\/clients\/\">TeepTrak pharmaceutical clients<\/a> consistently achieve payback within 6-12 months while building foundation capabilities for ongoing operational excellence initiatives.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<p><strong>What is the average OEE in pharmaceutical manufacturing?<\/strong><\/p>\n<p>The average OEE in pharmaceutical manufacturing ranges from 55-65%, significantly below the world-class benchmark of 85%. TeepTrak pharma clients achieve an average improvement of +11 OEE points within 5 months of implementation.<\/p>\n<p><strong>How does pharma OEE differ from automotive OEE?<\/strong><\/p>\n<p>Pharma OEE differs through batch production complexity, extensive changeover procedures requiring CIP\/SIP cleaning cycles lasting 4-8 hours, stringent regulatory documentation requirements, and equipment qualification downtimes for IQ\/OQ\/PQ protocols that can extend for days.<\/p>\n<p><strong>Is TeepTrak compliant with FDA 21 CFR Part 11 requirements?<\/strong><\/p>\n<p>Yes, TeepTrak maintains full FDA 21 CFR Part 11 compliance with electronic records and signatures, audit trails, data integrity following ALCOA+ principles, and secure user access controls required for regulated pharmaceutical environments.<\/p>\n<p><strong>What are the biggest OEE killers in pharmaceutical plants?<\/strong><\/p>\n<p>The six biggest OEE killers are: CIP\/SIP cleaning cycles (4-8 hours per changeover), equipment qualification downtime, batch record completion delays, in-process control failures, product changeovers, and micro-stoppages on filling and pressing lines that remain invisible without IoT monitoring.<\/p>\n<p><strong>How long does TeepTrak installation take in pharmaceutical facilities?<\/strong><\/p>\n<p>TeepTrak installation requires approximately 30 minutes per machine with zero production interruption. The wireless IoT sensors are designed for FDA\/GMP environments and can provide live OEE data within 48 hours of installation.<\/p>\n<p><strong>What ROI can pharmaceutical companies expect from OEE improvements?<\/strong><\/p>\n<p>For a typical $500M revenue pharmaceutical plant, each OEE percentage point represents $2-5M in annual value. TeepTrak clients typically achieve payback within 6-12 months through improved production capacity and reduced compliance risks.<\/p>\n<p><strong>How should pharmaceutical companies prepare for INTERPHEX 2026?<\/strong><\/p>\n<p>Companies should establish baseline OEE measurements before attending INTERPHEX 2026, prepare specific questions about FDA 21 CFR Part 11 compliance, deployment timelines, and batch management system integration to effectively evaluate IoT monitoring solutions.<\/p>\n<p>INTERPHEX 2026 represents a pivotal opportunity for pharmaceutical manufacturers to transform their operational effectiveness through advanced OEE monitoring technologies. The convergence of IoT capabilities, FDA-compliant data architectures, and proven implementation methodologies now enables pharmaceutical plants to achieve world-class efficiency performance while maintaining full regulatory compliance. TeepTrak stands ready to support this transformation with comprehensive solutions specifically designed for the unique requirements of pharmaceutical manufacturing environments.<\/p>\n<p style=\"text-align:center;margin-top:40px;\"><a href=\"https:\/\/teeptrak.com\/en\/demo\/\" style=\"background-color:#EB352C;color:#ffffff;padding:16px 32px;border-radius:4px;text-decoration:none;font-weight:bold;font-size:16px;\">Schedule Your Pharmaceutical OEE Assessment<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27&#8243;][et_pb_row][et_pb_column type=&#8221;4_4&#8243;][et_pb_text _builder_version=&#8221;4.27&#8243;] Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026 The pharmaceutical industry presents a striking paradox that challenges operational excellence professionals worldwide. Despite being one of the most regulated and highest-margin industries globally, with profit margins often exceeding 20-30%, the average OEE in pharmaceutical manufacturing hovers between just [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":83584,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","ai_seo_title":"","ai_meta_description":"","ai_focus_keyword":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-83590","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026 - TEEPTRAK - Connect to your industrial potential<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026 - TEEPTRAK - Connect to your industrial potential\" \/>\n<meta property=\"og:description\" content=\"[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27&#8243;][et_pb_row][et_pb_column type=&#8221;4_4&#8243;][et_pb_text _builder_version=&#8221;4.27&#8243;] Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026 The pharmaceutical industry presents a striking paradox that challenges operational excellence professionals worldwide. Despite being one of the most regulated and highest-margin industries globally, with profit margins often exceeding 20-30%, the average OEE in pharmaceutical manufacturing hovers between just [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"TEEPTRAK - Connect to your industrial potential\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-01T16:19:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-01T16:19:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/04\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1150\" \/>\n\t<meta property=\"og:image:height\" content=\"657\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9quipe TEEPTRAK\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9quipe TEEPTRAK\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/\"},\"author\":{\"name\":\"\u00c9quipe TEEPTRAK\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/#\\\/schema\\\/person\\\/f65d3615a0236cee859fbeed2c641e5c\"},\"headline\":\"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026\",\"datePublished\":\"2026-04-01T16:19:05+00:00\",\"dateModified\":\"2026-04-01T16:19:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/\"},\"wordCount\":2771,\"publisher\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026.jpeg\",\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/\",\"url\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/\",\"name\":\"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026 - TEEPTRAK - Connect to your industrial potential\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026.jpeg\",\"datePublished\":\"2026-04-01T16:19:05+00:00\",\"dateModified\":\"2026-04-01T16:19:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026.jpeg\",\"contentUrl\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026.jpeg\",\"width\":1150,\"height\":657,\"caption\":\"pharmaceutical manufacturing oee prepare factory interphex 2026 - TeepTrak pharma OEE\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/\",\"name\":\"TEEPTRAK\",\"description\":\"TEEPTRAK official website - OEE\",\"publisher\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/#organization\",\"name\":\"TEEPTRAK\",\"url\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/cropped-Capture-decran-2023-05-04-112832.png\",\"contentUrl\":\"https:\\\/\\\/teeptrak.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/cropped-Capture-decran-2023-05-04-112832.png\",\"width\":512,\"height\":512,\"caption\":\"TEEPTRAK\"},\"image\":{\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/teeptrak\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/teeptrakinternational\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/#\\\/schema\\\/person\\\/f65d3615a0236cee859fbeed2c641e5c\",\"name\":\"\u00c9quipe TEEPTRAK\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g\",\"caption\":\"\u00c9quipe TEEPTRAK\"},\"sameAs\":[\"https:\\\/\\\/teeptrak.com\"],\"url\":\"https:\\\/\\\/teeptrak.com\\\/en\\\/author\\\/auriane\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026 - TEEPTRAK - Connect to your industrial potential","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/","og_locale":"en_US","og_type":"article","og_title":"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026 - TEEPTRAK - Connect to your industrial potential","og_description":"[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27&#8243;][et_pb_row][et_pb_column type=&#8221;4_4&#8243;][et_pb_text _builder_version=&#8221;4.27&#8243;] Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026 The pharmaceutical industry presents a striking paradox that challenges operational excellence professionals worldwide. Despite being one of the most regulated and highest-margin industries globally, with profit margins often exceeding 20-30%, the average OEE in pharmaceutical manufacturing hovers between just [&hellip;]","og_url":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/","og_site_name":"TEEPTRAK - Connect to your industrial potential","article_published_time":"2026-04-01T16:19:05+00:00","article_modified_time":"2026-04-01T16:19:09+00:00","og_image":[{"width":1150,"height":657,"url":"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/04\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026.jpeg","type":"image\/jpeg"}],"author":"\u00c9quipe TEEPTRAK","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9quipe TEEPTRAK","Est. reading time":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/#article","isPartOf":{"@id":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/"},"author":{"name":"\u00c9quipe TEEPTRAK","@id":"https:\/\/teeptrak.com\/en\/#\/schema\/person\/f65d3615a0236cee859fbeed2c641e5c"},"headline":"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026","datePublished":"2026-04-01T16:19:05+00:00","dateModified":"2026-04-01T16:19:09+00:00","mainEntityOfPage":{"@id":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/"},"wordCount":2771,"publisher":{"@id":"https:\/\/teeptrak.com\/en\/#organization"},"image":{"@id":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/04\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026.jpeg","articleSection":["Non classifi\u00e9(e)"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/","url":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/","name":"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026 - TEEPTRAK - Connect to your industrial potential","isPartOf":{"@id":"https:\/\/teeptrak.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/#primaryimage"},"image":{"@id":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/04\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026.jpeg","datePublished":"2026-04-01T16:19:05+00:00","dateModified":"2026-04-01T16:19:09+00:00","breadcrumb":{"@id":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/#primaryimage","url":"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/04\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026.jpeg","contentUrl":"https:\/\/teeptrak.com\/wp-content\/uploads\/2026\/04\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026.jpeg","width":1150,"height":657,"caption":"pharmaceutical manufacturing oee prepare factory interphex 2026 - TeepTrak pharma OEE"},{"@type":"BreadcrumbList","@id":"https:\/\/teeptrak.com\/en\/pharmaceutical-manufacturing-oee-prepare-factory-interphex-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/teeptrak.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pharmaceutical Manufacturing OEE: How to Prepare Your Factory Before INTERPHEX 2026"}]},{"@type":"WebSite","@id":"https:\/\/teeptrak.com\/en\/#website","url":"https:\/\/teeptrak.com\/en\/","name":"TEEPTRAK","description":"TEEPTRAK official website - OEE","publisher":{"@id":"https:\/\/teeptrak.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/teeptrak.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/teeptrak.com\/en\/#organization","name":"TEEPTRAK","url":"https:\/\/teeptrak.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/teeptrak.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/teeptrak.com\/wp-content\/uploads\/2023\/05\/cropped-Capture-decran-2023-05-04-112832.png","contentUrl":"https:\/\/teeptrak.com\/wp-content\/uploads\/2023\/05\/cropped-Capture-decran-2023-05-04-112832.png","width":512,"height":512,"caption":"TEEPTRAK"},"image":{"@id":"https:\/\/teeptrak.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/teeptrak\/","https:\/\/www.linkedin.com\/company\/teeptrakinternational\/"]},{"@type":"Person","@id":"https:\/\/teeptrak.com\/en\/#\/schema\/person\/f65d3615a0236cee859fbeed2c641e5c","name":"\u00c9quipe TEEPTRAK","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c15a5bed2b22793c34b357757ed5a12321e733893599e115e40c0263ef4877f7?s=96&d=mm&r=g","caption":"\u00c9quipe TEEPTRAK"},"sameAs":["https:\/\/teeptrak.com"],"url":"https:\/\/teeptrak.com\/en\/author\/auriane\/"}]}},"_links":{"self":[{"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/posts\/83590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/comments?post=83590"}],"version-history":[{"count":1,"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/posts\/83590\/revisions"}],"predecessor-version":[{"id":83591,"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/posts\/83590\/revisions\/83591"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/media\/83584"}],"wp:attachment":[{"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/media?parent=83590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/categories?post=83590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teeptrak.com\/en\/wp-json\/wp\/v2\/tags?post=83590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}